arrow
C

Claudia Chiodoni

Fondazione IRCCS Istituto Nazionale dei Tumori
H指数:39
被引数:5,958

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Neoadjuvant botensilimab with or without balstilimab in pMMR and dMMR colon cancer: the phase 2 UNICORN trial

新辅助botensilimab联合或不联合balstilimab治疗pMMR和dMMR结肠癌: UNICORN 2期试验

2026-11-020
OAAI
ECM-Induced IL-23 Drives Immune Suppression in Breast Cancer via Regulating PD-1 on Tregs

ECM诱导的IL-23通过调控Tregs上的PD-1驱动乳腺癌中的免疫抑制

2025-10-030
OAAI
Tremelimumab and durvalumab as neoadjuvant or non-operative management strategy of patients with microsatellite instability-high resectable gastric or gastroesophageal junction adenocarcinoma: the INFINITY study by GONO

曲美木单抗和度伐利尤单抗作为微卫星不稳定性高、可切除的胃或胃食管结合部腺癌患者的新辅助治疗或非手术治疗策略:GONO开展的INFINITY研究

2025-03-018
PRE
CD36 enrichment in HER2-positive mesenchymal stem cells drives therapy refractoriness in breast cancer

CD36富集在HER2阳性间充质干细胞中,驱动乳腺癌的治疗抵抗性

2025-01-201
OA
ZEB1 shapes AML immunological niches, suppressing CD8 T cell activity while fostering Th17 cell expansion
2024-02-011
OAAI